本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
MANCHESTER, England, June 23, 2023 /PRNewswire/ -- SmartKem, Inc. ("SmartKem" or the "Company") (OTCQB: SMTK), a company seeking to reshape the world of electronics with its disruptive organic thin-film transistors (OTFTs), today announced that it had sold in the final closing of its previously-announced private placement an aggregate of (i) 1,870.36596 shares of its Series A-1 Convertible Preferred Stock, stated value $1,000 per share, (ii) 100 shares of its Series A-2 Convertible Preferred Stock, stated value $1,000 per share, and (iii) Class A Warrants to purchase up to 7,881,464 shares of its common stock, for aggregate gross proceeds of approximately $2.0 million before deducting cash placement agent fees and other offering expenses. The shares of A-1 Convertible Preferred Stock are initially convertible into an aggregate of 7,481,464 shares of common stock of the Company, and the shares of Series A-2 Convertible Preferred Stock are initially convertible into an aggregate of 400,000 shares of common stock of the Company, in each case, at a conversion price of $0.25 per share. The Class A Warrants have an exercise price of $0.25 per share, are exercisable immediately, and will expire five years from the date of issuance. The private placement is now complete. SmartKem received a total gross proceeds of approximately $14.2 million in the private placement. SmartKem intends to use the total net proceeds from the private placement for working capital and general corporate purposes. The Special Equities Group, a division of Dawson James Securities, Inc., and Katalyst Securities LLC acted as the placement agents for the private placement. The securities offered in the private placement are being offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and/or Rule 506(b) of Regulation D promulgated thereunder and have not been registered under the Act or applicable state securities laws. Accordingly, the securities may not be offered or sold in the United States absent registration with the Securities and Exchange Commission (the "SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of the common stock underlying the Series A-1 Preferred Stock, Series A-2 Preferred Stock and Class A Warrants no later than forty-five days following the final closing of the private placement. This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction. SmartKem's OTCQB information can be found on the OTC Markets website: www.otcmarkets.com/stock/SMTK/overview About SmartKem SmartKem is seeking to reshape the world of electronics with its disruptive organic thin-film transistors (OTFTs) that have the potential to drive the next generation of displays. SmartKem's patented TRUFLEX® semiconductor and dielectric inks, or liquid electronic polymers, are used to make a new type of transistor that could potentially revolutionize the display industry. SmartKem's inks enable low temperature printing processes that are compatible with existing manufacturing infrastructure to deliver low-cost displays that outperform existing models. The company's electronic polymer platform can be used in a number of display technologies including microLED, miniLED and AMOLED displays for next generation televisions, laptops, augmented reality (AR) and virtual reality (VR) headsets, smartwatches and smartphones. SmartKem develops its materials at its research and development facility in Manchester, UK, its semiconductor manufacturing processes at the Centre for Process Innovation (CPI) at Sedgefield, UK and retains a field application office in Taiwan. The company has an extensive IP portfolio including 125 granted patents across 19 patent families and 40 codified trade secrets. For more information, visit: www.smartkem.com and follow us on LinkedIn and Twitter @SmartKemTRUFLEX. Forward-Looking Statements All statements in this press release that are not historical are forward-looking statements, including, among other things, the intended use of proceeds from the private placement, SmartKem's expectations regarding its market position and market opportunity, expectations and plans as to its product development, manufacturing and sales, and relations with its partners and investors. These statements are not historical facts but rather are based on SmartKem Inc.'s current expectations, estimates, and projections regarding its business, operations and other similar or related factors. Words such as "may," will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expect," "intend," "plan," "project," "believe," "estimate," and other similar or elated expressions are used to identify these forward-looking statements, although not all forward-looking statements contain these words. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, and assumptions that are difficult or impossible to predict and, in some cases, beyond the Company's control. Actual results may differ materially from those in the forward-looking statements as a result of a number of factors, including those described in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to revise or update information in this release to reflect events or circumstances in the future, even if new information becomes available.
台北2023年6月23日 /美通社/ -- 北美生物科技產業展（BIO International Convention）由全球生技協會（Biotechnology Innovation Organization，BIO）主辦，是全球最具規模的生技醫藥展會和論壇，匯聚全球各地的產業領袖、科學家、研究人員、國際級投資人和創投家、以及病人權益倡導者等，堪稱全球生技界之年度盛事。今年的展會（下稱 BIO 2023）於 6 月 5 日至 8 日在波士頓隆重舉行，本屆大會以「為科學站起來（Stand Up for Science）」主題，旨在呈現與表揚生物科技為人類社會帶來的突破。為期 4 天的實體展會合共舉辦了約 150 場會議，有 800 名演講者參與其中，估計吸引了來自 60 多個國家及地區超過 15,000 名代表共襄盛舉，一同探討產業重要議題和最新趨勢、分享研究經驗、並推動國際商務合作。 參加 2023 北美生物科技產業展（BIO International Convention）的台灣代表團成員及來訪嘉賓。 產官學研精英齊聚波士頓，台灣生醫代表團大放異彩 參與 BIO 2023 的台灣生醫代表團由行政院政務委員暨國家科學及技術委員會（國科會）主任委員吳政忠領軍，成員約有 250 人。當中執行團隊包括經濟部生技醫藥發展推動小組（BPIPO）和外貿協會（TAITRA），以及來自經濟部工業局、國家發展委員會、衛生福利部、行政院農業委員會、中央研究院、工業技術研究院及生物技術開發中心（生技中心）等政府代表與法人單位。代表團還有近 90 家隨團廠商和 50 多家參展商，旨在展現台灣生醫產業創新格局，將新銳技術和產品帶到國際舞台。代表團不僅在 BIO 2023 開幕前在波士頓舉辦台灣生物技術論壇（Taiwan Biotech Forum），並在 6 月 6 日舉辦台灣館開幕及 Happy Hour 活動。 BIO 2023 台灣館載譽重來，展現生醫發展卓越成就 延續往年的成功，今年台灣代表團繼續在 BIO 2023 期間設置台灣形象館（Taiwan Pavilion），展現台灣生醫發展的多樣性，並與國際重量級廠商和投資人建立鏈結，打造國際研發合作網絡，提高台灣在國際生技界的能見度。 本年度台灣館參展公司總數由 2022 年的 33 家大幅上升至今年的 51 家，規模在全體參展國家及地區中位列第九，且涵蓋新藥開發、生物技術、核酸藥物 CDMO、醫療器材、精準健康、再生醫學、農業生物技術、小分子藥物、智慧健康等多個領域。此外也有多項備受注目的創新技術和服務在台灣館隆重登場，包括以 AI 判讀心血管疾病、3D 病理組織處理及影像技術、仿生腫瘤類器官培養系統與蛋白質新藥一站式製造服務等。本次更展出台灣智慧醫院解決方案，從後端醫院資訊系統、到前端精準醫療 AI 診斷工具與微創手術影像串流技術，均由醫院、資通訊與生醫業者共同建立，有望開創台灣未來醫療的新趨勢。 在 6 月 6 日舉行的台灣館開幕及 Happy Hour 活動中，除了有台灣代表團的成員外，全球生技協會（BIO）執行長 Rachel King、台灣駐波士頓辦事處長孫儉元、美國麻州經濟發展廳廳長郝依平（Yvonne Hao）、紐澤西非營利經濟發展組織招商局（Choose New Jersey）局長 Wesley Mathews 等，以及瑞士、日本、羅德島、麻州等產業協會的代表都親臨現場祝賀，250 人齊聚一堂，熱烈歡迎台灣生技廠商到來。 身兼 BPIPO 主任、生技中心執行長及台灣生物產業發展協會（Taiwan BIO）理事長的吳忠勳博士在 Happy Hour 致詞中強調，台灣是國際藥廠和生技公司前往亞洲發展的最佳合作夥伴。台灣擁有優越的地理位置，前往亞洲幾個最重要的城市都可以在 5 小時內到達，是連接美洲、歐洲和亞太地區的關鍵角色。 全球生技協會（BIO）與 Taiwan BIO 亦於活動當日宣佈將會續簽長達三年的合作關係，並由兩大組織的領導人舉行換約儀式，同時有台灣代表團團長吳政忠在場見證。BIO 與 Taiwan BIO 在 2024 至 2026 年期間將繼續在台灣合辦 BIO Asia-Taiwan 亞洲生技大會。透過雙方共同宣傳活動，參與 BIO ASIA–Taiwan 的廠商不僅能串接亞洲生技價值鏈，更能在全世界佔有更大的生技市場，獲得更多國際合作機會。BIO 執行長 Rachel King 高度讚揚台灣生技的發展潛力以及近年來的快速進步，期待在未來可以看見台灣生技產業大放異彩。 此外，經濟部工業局楊志清副局長在接受基因線上採訪時提到：「台灣業界善於整合，並且利用在軟體硬體相關的優勢，開發出國際供應鏈所需要的技術。我們的領域非常多元，不管是從精準健康、CDMO、以及智慧醫療，都有相關的展會來做展示。我們的業界成員也非常多元，不管是新創中小企業以及成熟的公司都有參與，可見台灣的產業是相當蓬勃且充滿活力。」 台灣參展 BIO 2023 成果豐厚，多家新創企業再創佳績 自 2017 年首次舉辦以來，BIO 展會的「新創競技場（Start-Up Stadium）」環節為全球生技新創企業提供了一個展示技術研發成果、接觸重量級投資人、連結國際市場的絕佳平台。在 BIO 2023 中，報名參賽的台灣生醫新創團隊的從去年的 14 隊增加到 20 隊。此外，繼去年首度有台灣團隊躋身決賽之後，今年再次有台灣生技企業成功進入 Start-Up Stadium 最終決選，數目更由去年的兩家增至五家。 另外，台灣今年再次獲大會邀請參加「全球創新中心專題演講（Global Innovation Hub Presentations）」項目。此次台灣派出 Taiwan BIO 吳忠勳理事長擔任講者，演講中他再次提到台灣是亞太地區精準醫療的理想合作夥伴，強調台灣在科技創新、商業環境、高科技產業發展和政府配套支持各方面均具競爭優勢。 總括而言，參加 BIO 2023 的台灣生技公司反應都非常正面，紛紛表示展會有助他們與世界各地的產業領袖和投資人建立連結，帶來寶貴的商業機會。而政府單位代表則認為參與此次國際盛會能夠讓他們更有效掌握全球生技醫藥界尖端趨勢，以便更好地調整政策，從而推動台灣生技研究和產業發展。
TAIPEI, June 23, 2023 /PRNewswire/ -- BIO International Convention is the world's largest international biotech industry exhibition and forum organized by the Biotechnology Industry Organization (BIO) in the U.S. every year. It is the annual main event of the global biopharma sector that brings together industry leaders, top-notch scientists, leading investors and venture capitalists from around the globe, together with representatives of research institutes and universities, government agencies, non-profit organizations, and patient advocacy groups. Members of the Taiwan delegation and distinguished guests participating in BIO 2023 at the Taiwan Pavilion. With the theme "Stand Up for Science" that honors and recognizes the true value of the breakthrough work biotech performs for society, the BIO 2023 Convention (BIO 2023) took place from June 5 to 8 in Boston, one of the world's premier biotech hubs. The 4-day on-site event hosted 150 sessions featuring 800 speakers and attracted over 15,000 delegates from more than 60 countries and regions, getting together to network, learn and collaborate on the latest trends and innovations in the industry. Uniting Government and Industry Elites, Taiwan's Delegation Made a Remarkable Appearance at BIO 2023 Under the leadership of Dr. Wu Tsung-tsong, Minister of Science and Technology Council, a large Taiwanese delegation with about 250 members traveled to Boston to attend BIO 2023. The executive team consisted of consisted of the Biotechnology and Pharmaceutical Industries Promotion Office (BPIPO) and the Taiwan External Trade Development Council (TAITRA), along with representatives from the Industrial Development Bureau (IDB) of the Ministry of Economic Affairs (MOEA), National Science and Technology Council, Council of Agriculture, National Development Council, Academia Sinica, Ministry of Health and Welfare, and the Development Center for Biotechnology (DCB). The delegation also featured over 80 participating companies and 51 exhibitors, with the aim of bringing the most promising technologies and products of Taiwan's biotech industry to the international stage. Not only did they organize the Taiwan Biotech Forum prior to the opening of BIO 2023, they also hosted the "Taiwan Pavilion Happy Hour" on June 6. Taiwan Pavilion at BIO 2023 Showcased the Excellence of Taiwan's Biomedical Development Following the success of previous years, the Taiwan delegation continued hosting the "Taiwan Pavilion" during BIO 2023 to showcase the diversity and excellence of Taiwan's biomedical development, establishing connections with world-class manufacturers and investors, creating an international R&D cooperation network, and enhancing Taiwan's exposure in the international biotech community. In BIO 2023, the total number of exhibitors at the Taiwan Pavilion jumped from 33 in 2022 to 51, ranking ninth in size among all participating countries and regions and covering various fields such as biopharmaceuticals, biotechnology, medical devices, nucleic acid therapeutics CDMO, regenerative medicine, agriculture biotechnology, precision medicine, small molecule drugs, and smart health. In addition, the pavilion featured many notable innovative technologies and services, including an AI platform for rapid ECG interpretation and diagnosis of 20 cardiovascular diseases, a 3D pathology tissue processing and imaging technology, a tumor organoid culture system, and a one-stop manufacturing service for novel protein-based drugs. Furthermore, on display were the Taiwan Smart Healthcare Solutions, from the back-end hospital information system to the front-end medical AI diagnostic tools and the image streaming technology for minimally invasive surgery, all jointly created by hospitals, ICT businesses and biomedical professionals, potentially creating a brand new trend in Taiwan's future healthcare. Taiwan Pavilion Yielded Great Results with Participation of U.S. Delegates At the opening and Happy Hour of the Taiwan Pavilion on June 6, in addition to members of the Taiwan delegation, Rachel King, CEO of BIO, Jonathan C. Y. Sun, Director-General of Taipei Economic and Cultural Office in Boston, Yvonne Hao, Secretary of the Executive Office of Economic Development, Wesley Mathews, President and CEO of Choose New Jersey, along with representatives of industry associations from Switzerland, Japan, Rhode Island and Massachusetts were also present to extend a warm welcome to Taiwan biotech companies. Dr. Chung-Hsun Wu, Director of BPIPO, CEO of DCB and Chairman of the Taiwan Bio Industry Organization (Taiwan BIO), emphasized in his address during the Happy Hour that Taiwan is an excellent partner for international biotech and pharmaceutical companies looking for opportunities in Asia. With its excellent geographical location, Taiwan is within 5 hours of major Asian cities and is a key player in connecting the Americas, Europe and the Asia-Pacific region. During the event, Biotechnology Industry Organization (BIO) and Taiwan BIO announced the renewal of their cooperation for three years from 2024 to 2026, and a contract exchange ceremony was held between the leaders of two organizations. They will continue to co-organize the annual biotech event BIO Asia-Taiwan, and through their joint promotion activities, it will provide more opportunities for participating companies to gain access to international cooperation not only in Asia but also around the world. BIO's CEO Rachel King pointed out that Taiwan's biotech market has great potential, and its advances in recent years have been well known. It is anticipated that Taiwan's biotech industry may shine in the future. In an interview, Mr. Chih-ching Yang, IDB's Deputy Director General, mentioned that Taiwan's industry excelled in integration and capitalizing on its strengths in software and hardware to develop technologies needed for the international supply chain. The delegation this year is diversified in terms of domains and company size, with services covering precision medicine, CDMO, and smart healthcare, and exhibitors also include start-ups, small and medium-sized enterprises, and mature biotech companies, showing that Taiwan's biomedical industry is highly dynamic and energetic. Taiwan Reaches New Heights in the Start-Up Stadium and Shines at Global Innovation Hub Presentations Since its debut in 2017, the Start-Up Stadium at the BIO International Convention provides biotech start-up companies with an opportunity to showcase their technologies and engage key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital. In BIO 2023, the number of Taiwanese biomedical start-up teams enrolled in the contest increased from 14 last year to 20. Further, after the first appearance of Taiwanese teams in the finals in 2022, five companies were selected as finalists this year, compared to two teams last year. This year, Taiwan was once again invited to participate in the Global Innovation Hub Presentations program, where Taiwan BIO's Chairman Dr. Chung-hsiun Wu made a presentation that illustrated related facts that Taiwan is an "Ideal Partner for Precision Health in Asia Pacific", highlighting Taiwan's competitive edges in terms of innovation, business environment, ideal application, high-tech industry development and strong government support. Overall, companies that attended the BIO 2023 shared their overwhelmingly positive experience at the event, meetings with business leaders and investors from around the world brought invaluable business opportunities, while government representatives gained impressive insights into global biotech trends to better adapt policies to encourage research and business developments.
Acclaimed artist Kuchichun has officially joined the UK Gallery Climate Coalition, a prominent collective dedicated to fostering sustainable practices within the art world. As a member, Kuchichun aims to promote the integration of Environmental, Social, and Governance (ESG) principles into artistic creation, emphasizing the importance of climate action and sustainability. The UK Gallery Climate Coalition, a network of galleries, artists, and cultural institutions, strives to address the pressing environmental challenges we face today. By uniting the creative community, the coalition aims to raise awareness, inspire change, and lead the art world towards a more sustainable future. For more information about the coalition, please visit their official website at www.galleryclimatecoalition.org. Kuchichun, known for their thought-provoking and visually captivating artwork, has consistently advocated for environmental consciousness and social responsibility through their creations. By joining the Gallery Climate Coalition, Kuchichun further strengthens their commitment to these values and collaborates with like-minded individuals and organizations. With a focus on ESG-inspired artistic creation, Kuchichun's work explores themes of sustainability, climate justice, and human impact on the environment. Through their art, they aim to spark conversations, inspire action, and encourage viewers to contemplate their role in creating a more sustainable world. To learn more about Kuchichun and their artistic endeavors, please visit their official website at www.kuchichunart.com. The addition of Kuchichun to the UK Gallery Climate Coalition brings valuable insights, artistic talent, and a strong commitment to environmental stewardship. Together, they will work towards raising awareness about climate change, promoting sustainable practices within the art community, and leveraging art as a powerful tool for social and environmental transformation.
An exciting announcement unfolds in Mannheim, Germany, as a new art space, Kyla x Eniziart Gallery, opens its doors with a mission focused on Sustainable Development Goals (SDGs). This brand-new art gallery serves as a hub for artists, cultural exchange, and sustainability, inviting the citizens of Mannheim and visitors to be inspired and provoked by the artworks on display. The establishment of Kyla x Eniziart Gallery reaffirms Mannheim's position as a center for art and culture. This gallery showcases Asian artists and their artworks, offering a gateway to a new realm of artistic expression for the local community. Kyla x Eniziart Gallery is not only a space of aesthetic beauty but also holds a strong commitment to the United Nations' Sustainable Development Goals. By integrating these goals into their artworks and exhibitions, the gallery aims to raise awareness about crucial global challenges and promote sustainable transformation. The gallery warmly invites all art enthusiasts and curious individuals to explore the diverse works by Asian artists and experience a unique cultural journey. From paintings to sculptures and multimedia installations, a wide range of artworks awaits, pushing the boundaries of creativity and expression. Located in a central area of Mannheim, Kyla x Eniziart Gallery is open from Tuesday to Sunday, 10:00 AM to 6:00 PM. Admission is free, and visitors are encouraged to participate in the regularly held events and exhibition openings. Kyla x Eniziart Gallery invites you to discover the fascination of Asian art and contribute together towards a sustainable future.
Visitor registration is open to all trade visitors in the beauty industry KUALA LUMPUR, Malaysia, June 22, 2023 /PRNewswire/ -- Having seen an overwhelming response in 2022, Informa Markets is proud to announce the beautyexpo (21st edition) & Cosmobeauté Malaysia (18th edition) from 27 to 30 September 2023 at Kuala Lumpur Convention Centre (KLCC)! The show is set to make a significant impact this year with bigger halls and exciting highlights, providing exhibitors with an unparalleled opportunity to showcase their latest products and innovations in the beauty industry. Register to beautyexpo & Comobeauté Malaysia (BECBM) 2023 to explore the latest trends, innovations, and offerings in the ever-evolving beauty landscape. As Malaysia's largest and longest-running beauty trade shows, beautyexpo & Cosmobeauté Malaysia 2023 focuses on the forefront of beauty, showcasing innovative products with cutting-edge technology while advocating for a more sustainable market in the beauty industry. This years' show anticipates the participation of 350 exhibitors and top brands from an array of beauty sectors including Aesthetic and Spa, Hair and Nail, OEM / ODM, Professional & Skincare Products. As borders reopen and international trade resumes, countries and regions such as Mainland China, Hong Kong, India, Indonesia, Japan, Korea, Singapore, Taiwan, United Arab Emirates and Vietnam are onboarded at the show, bringing their new products and services to reconnect with buyers for new business opportunities. beautyexpo & Cosmobeauté Malaysia 2023 is also expected to welcome 10,000 visitors across the world, gathering top-level industry professionals showcasing both emerging and leading brands, maximising business and networking opportunities between exhibitors and buyers. "beautyexpo & Cosmobeauté Malaysia is fully committed to supporting businesses to revitalise and fortify the ever-changing beauty industry, which has been redefined by the pandemic. As the organisers, we are tremendously grateful to each and every stakeholder, including our global exhibitors, supporting partners, sponsors, media partners, and visitors, who have shown devoted commitment to our shows. Together, we are reshaping the next generation of beauty, with invaluable contributions from all, so that we can continue to innovate and evolve the industry", says Gerard Leeuwenburgh, Country General Manager of Informa Markets Malaysia. With unwavering support from beauty associations including Association of International Certified Aesthetician (AICA), Federation of Asian Beauty Industry Association (FABIA), International Beauty Industry Trade Association (IBITA), Kuching Association of Beauty Therapy & Cosmetology (KABTAC), Malaysia Cosmetology Chamber of Commerce (PAMM), Malaysian Hairdressing Association (MHA) and United Asian Hairdressers Association (UAHA), beautyexpo and Cosmobeauté Malaysia 2023 strives to foster inclusivity among the industry professionals and the beauty community around the world. "We are intensifying our efforts to unite all of our association members at beautyexpo and Cosmobeauté Malaysia, recognising the importance of collaboration and knowledge sharing in advancing the beauty aesthetic industry. By doing so, we can shape the industry's future and inspire a forward-thinking mindset among industry players," shares Prof. Dr. Ng Wee Kiong, Founder & President of AICA. "We are committed to advance the hair care industry in Malaysia, and we recognise the important role that beautyexpo and Cosmobeauté Malaysia play in driving innovation and progress. The show also provides us an opportunity to foster innovation, drive growth, and create valuable opportunities for businesses and professionals alike within the hairdressing industry", says Dr. Michael Poh, President of MHA & UAHA. "beautyexpo and Cosmobeauté Malaysia meets the industry demands by playing an indispensable role in connecting the beauty industry. The shows offer a various resource for product discovery, business opportunities, networking, and knowledge sharing, making it a premier platform for all stakeholders. We take great pride in supporting beautyexpo and Cosmobeauté Malaysia, recognising the show's significant contributions to the beauty industry," states Alvin Loh, Asia Pacific President of FABIA & Chairman of PAMM. beautyexpo & Cosmobeauté Malaysia are renowned as the ultimate B2B sourcing destination and a platform for discovering trusted, original brands, making them a reliable solution for businesses to explore, establish and enhance their product and service distribution networks internationally. Apart from that, the show features engaging events and exciting activities providing visitors with the opportunity to gain new insights, knowledge and the latest skillsets. Some of the highlights are: Barber Competition & Hair Show Competition presented by Andis & BaBylissPRO ambassadors Industry Seminars: Latest Beauty & Hair Trend Seminars Conducted by Industry Experts The Crowning Glory Awards Ceremony 2023: The Most Prestigious Hairdressing Awards Ceremony Fabulous and Extravagant Hair Shows 3rd Malaysia Glory Cup: International Beauty Professionals Competing for the Championship in Three Categories: Embroidery, Eyelash, and Nail Luxe Beauty Gallery: 1st Inaugural Top Product Awards by Beauty Industry Leaders VIP Buyer Programme with Exclusive Perks and Trade Opportunities Spend & Win to reward Visitors Visitor registration is now open, be inspired and unlock new opportunities at the show! Register your visit at https://bit.ly/43Oqt8F. To exhibit at beautyexpo and Cosmobeauté Malaysia, please email info.becbm@informa.com. For more information about beautyexpo and Cosmobeauté Malaysia, visit the official websites at www.beautyexpo.com.my and www.cosmobeauteasia.com/malaysia. To get latest news and insights, follow us on Facebook at www.facebook.com/beautyexpomalaysia and www.facebook.com/cosmobeautemalaysia. NOTES TO EDITORS:ABOUT INFORMA MARKETS (www.informamarkets.com) Informa Markets on Beauty segment has an extensive network powered by B2B events across 11 cities in Asia (Bangkok, Chengdu, Ho Chi Minh City, Hong Kong, Jakarta, Kuala Lumpur, Manila, Mumbai, Shanghai, Shenzhen, Tokyo), the world's fastest growing markets. By further expanding its strength, the Beauty Portfolio now includes a new B2B event in Miami serving the East coast and USA, South America and Caribbean Islands regions. beautyexpo & Cosmobeauté Malaysia is organised by Informa Markets, a division of Informa plc. Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world's leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
A12 藝術空間
i-Taiwan
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
